======= CHRNA2 ======= == Gene Information == * **Official Symbol**: CHRNA2 * **Official Name**: cholinergic receptor nicotinic alpha 2 subunit * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1135|1135]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q15822|Q15822]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CHRNA2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CHRNA2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/118502|Open OMIM]] == Function Summary == * **Entrez Summary**: Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels formed by a pentameric arrangement of alpha and beta subunits to create distinct muscle and neuronal receptors. Neuronal receptors are found throughout the peripheral and central nervous system where they are involved in fast synaptic transmission. This gene encodes an alpha subunit that is widely expressed in the brain. The proposed structure for nAChR subunits is a conserved N-terminal extracellular domain followed by three conserved transmembrane domains, a variable cytoplasmic loop, a fourth conserved transmembrane domain, and a short C-terminal extracellular region. Mutations in this gene cause autosomal dominant nocturnal frontal lobe epilepsy type 4. Single nucleotide polymorphisms (SNPs) in this gene have been associated with nicotine dependence. [provided by RefSeq, Nov 2009]. * **UniProt Summary**: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. |Neur chan memb| |Neur chan LBD| |acetylcholine receptor activity| |acetylcholine-gated cation-selective channel activity| |acetylcholine-gated channel complex| |acetylcholine binding| |extracellular ligand-gated ion channel activity| |excitatory postsynaptic potential| |chemical synaptic transmission, postsynaptic| |regulation of postsynaptic membrane potential| |protein heterooligomerization| |postsynaptic membrane| |synapse| |neuron projection| |chemical synaptic transmission| |anterograde trans-synaptic signaling| |cell surface receptor signaling pathway involved in cell-cell signaling| |regulation of membrane potential| |trans-synaptic signaling| |synaptic signaling| |protein complex oligomerization| |cell junction| |ion transmembrane transport| |cell-cell signaling| |transmembrane transport| |ion transport| |nervous system process| |integral component of plasma membrane| |protein-containing complex assembly| |protein-containing complex subunit organization| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp143|Phenformin 20μM R03 exp143]]|-1.77| |[[:results:exp134|MS023 2μM R03 exp134]]|-1.76| |[[:results:exp241|QNZ 0.01μM R05 exp241]]|-1.7| |[[:results:exp505|ML-792 0.2μM R08 exp505]]|2.17| ^Gene^Correlation^ |[[:human genes:g:golga6l1|GOLGA6L1]]|0.536| |[[:human genes:p:prim1|PRIM1]]|0.44| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3971 * **Expression level (log2 read counts)**: -0.03 {{:chemogenomics:nalm6 dist.png?nolink |}}